prnasiaApril 22, 2020
Tag: Icon Group , ASEAN , cancer care
Patients in Singapore and the ASEAN region can now receive care as close to home as possible through Icon Cancer Centres' remote support services which include telemedicine and home delivery for medication. This service ensures minimal disruption to the care of cancer patients as the region battles COVID-19, alleviating immediate health concerns amidst travel restrictions for those whose cancer treatment has been affected.
An award-winning oncology-focused healthcare group, Icon Cancer Centre in Singapore has extended its remote support services since 7th April 2020 to enable patients access to specialists and medication locally or overseas.
Aside from remote support services out of Singapore, Icon has also extended care for cancer patients through its shared care network, enabling patients to be cared for in partner facilities across ASEAN. Icon's shared care network has been established over the years with partner clinicians and hospital facilities for patients who require urgent medical attention when they are at home. This network offers peace of mind to patients and their family members during the challenges of COVID-19.
Ms Serena Wee, CEO of Icon Cancer Centre, said that half the group's patients are from the region. "The travel restrictions have a big impact on their treatment. Hence, the urgency to offer alternative options of on-going care for our patients so that their care will be minimally interrupted."
"Icon believes in collaborating with partners for our patients' best outcomes. We're always reaching out to partners to fulfil Icon's mission of providing access to the best care possible to as many people as possible, as close to home as possible. It is especially important during this pandemic."
HOW IT WORKS:
BENEFITS:
CPhI China 2020 To Be Postponed to Dec. 16-18th,
Register as Visitor to the 20th Edition of CPhI China!
-----------------------------------------------------------------------
Editor's Note:
En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the articles,
please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: